This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1992 Feb 8;339(8789):365.

doi: 10.1016/0140-6736(92)91684-z.

Thalidomide enantiomers

W Winter, E Frankus

PMID: 1346437
DOI: 10.1016/0140-6736(92)91684-z

Comment

Thalidomide enantiomers

W Winter et al. Lancet. 1992.

. 1992 Feb 8;339(8789):365.

doi: 10.1016/0140-6736(92)91684-z.

Authors

W Winter, E Frankus

PMID: 1346437
DOI: 10.1016/0140-6736(92)91684-z

No abstract available

PubMed Disclaimer

Comment on

Chirality in antirheumatic drugs.
Kean WF, Lock CJ, Howard-Lock HE. Kean WF, et al. Lancet. 1991 Dec 21-28;338(8782-8783):1565-8. doi: 10.1016/0140-6736(91)92382-c. Lancet. 1991. PMID: 1683980 Review.

Similar articles

[Chromatographic separation of racemic thalidomide and teratogenic activity of its enantiomers (author's transl)].
Blaschke G, Kraft HP, Fickentscher K, Köhler F. Blaschke G, et al. Arzneimittelforschung. 1979;29(10):1640-2. Arzneimittelforschung. 1979. PMID: 583234 German.
Enantioselective inhibition of TNF-alpha release by thalidomide and thalidomide-analogues.
Wnendt S, Finkam M, Winter W, Ossig J, Raabe G, Zwingenberger K. Wnendt S, et al. Chirality. 1996;8(5):390-6. doi: 10.1002/(SICI)1520-636X(1996)8:5<390::AID-CHIR6>3.0.CO;2-I. Chirality. 1996. PMID: 8900028
Teratogenicity and embryotoxicity of thalidomide and 3-aza-thalidomide in mice.
Fickentscher K, Köhler F. Fickentscher K, et al. Pharmacology. 1974;11(4):193-8. doi: 10.1159/000136489. Pharmacology. 1974. PMID: 4460011 No abstract available.
Chirality and drug targeting: pros and cons.
Lien EJ. Lien EJ. J Drug Target. 1995;2(6):527-32. doi: 10.3109/10611869509015923. J Drug Target. 1995. PMID: 7773615 Review.
Chemical structure and teratogenic properties. 3. A review of available data on structure-activity relationships and mechanism of action of thalidomide analogues.
Jönsson NA. Jönsson NA. Acta Pharm Suec. 1972 Dec;9(6):521-42. Acta Pharm Suec. 1972. PMID: 4571160 Review. No abstract available.

See all similar articles

Cited by

Synthetic Studies of 3-(3-Fluorooxindol-3-yl)-l-alanine.
Fujiwara T, Yin B, Jin M, Kirk KL, Takeuchi Y. Fujiwara T, et al. J Fluor Chem. 2008;129(9):829-835. doi: 10.1016/j.jfluchem.2008.06.026. J Fluor Chem. 2008. PMID: 19122889 Free PMC article.
Thalidomide-induced limb malformations: an update and reevaluation.
Collins MD, Scott WJ. Collins MD, et al. Arch Toxicol. 2025 May;99(5):1643-1747. doi: 10.1007/s00204-024-03930-z. Epub 2025 Apr 8. Arch Toxicol. 2025. PMID: 40198353 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database